- Trials with a EudraCT protocol (179)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
179 result(s) found for: Femoral Bone.
Displaying page 1 of 9.
EudraCT Number: 2012-002010-39 | Sponsor Protocol Number: ORTHO-2 | Start Date*: 2014-04-11 | ||||||||||||||||
Sponsor Name:Universidad Autónoma de Madrid | ||||||||||||||||||
Full Title: Evaluation of safety and feasibility of bone marrow derived autologous MSCs to enhance bone healing in patients with avascular necrosis of femoral head | ||||||||||||||||||
Medical condition: Early avascular necrosis of the femoral head (MRI diagnosis): Ficat and Arlet 0, 1, or 2 (Steinberg stages 0, I, IIA, IIB, or IIC) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) IT (Ongoing) ES (Ongoing) RO (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000886-35 | Sponsor Protocol Number: AloFem | Start Date*: 2018-06-27 | |||||||||||||||||||||
Sponsor Name:Enrique Gomez-Barrena | |||||||||||||||||||||||
Full Title: Evaluation of safety, feasibility and preliminary efficacy of MSCs from third party donors in the treatment of patients with osteonecrosis of the femoral head after allogeneic Stem Cell Transplanta... | |||||||||||||||||||||||
Medical condition: Osteonecrosis of the Femoral Head | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000624-20 | Sponsor Protocol Number: ILONA | Start Date*: 2021-06-17 | |||||||||||
Sponsor Name:Leipzig University | |||||||||||||
Full Title: Core decompression versus core decompression followed by infusion of Iloprost in the treatment of non-traumatic avascular necrosis of the femoral head | |||||||||||||
Medical condition: non-traumatic avascular necrosis of the femoral head (N-ANFH) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015939-33 | Sponsor Protocol Number: 20080394 | Start Date*: 2010-03-23 |
Sponsor Name:Amgen Inc | ||
Full Title: A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Determine the Efficacy, Safety, and Tolerability of AMG 785 in Adults with Fresh Unilateral Intertrochanteric Fracture of the P... | ||
Medical condition: Acceleration of fracture healing | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: FR (Completed) GB (Completed) DE (Completed) SE (Completed) PL (Completed) DK (Completed) NL (Completed) LV (Completed) GR (Completed) IT (Completed) HU (Completed) BE (Completed) FI (Completed) LT (Completed) EE (Completed) BG (Completed) SI (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-001116-65 | Sponsor Protocol Number: B3D-MC-GHDQ | Start Date*: 2012-02-10 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: Second study on the Effect of Teriparatide on Femoral Neck Fracture Healing | |||||||||||||
Medical condition: Low trauma femoral neck fracture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BE (Completed) GR (Completed) PL (Completed) NL (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004149-33 | Sponsor Protocol Number: 05-FNF-007 | Start Date*: 2006-01-30 | |||||||||||
Sponsor Name:Stryker Biotech, LLC | |||||||||||||
Full Title: A randomized, controlled trial of the effect of Osigraft when used in the treatment of displaced femoral neck fractures – a pilot study | |||||||||||||
Medical condition: Displaced femoral neck fractures are classified as Garden III and IV according to the Garden classification system for femoral neck fractures. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005529-37 | Sponsor Protocol Number: 07.12.2015 | Start Date*: 2016-02-29 | |||||||||||
Sponsor Name:Bente Lomholt Langdahl | |||||||||||||
Full Title: Treatment with zoledronic acid subsequent to denosumab in osteoporosis | |||||||||||||
Medical condition: Osteoporosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005581-39 | Sponsor Protocol Number: CL3-12911-025 | Start Date*: 2007-04-02 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: A double-blind, multicenter, international randomised study to assess the effects of 6 months or 12 months administration of 2g per day of strontium ranelate versus alendronate 70mg per week on bo... | |||||||||||||
Medical condition: Treatment of postmenopausal Osteoporosis to reduce the risk of hip and vertebral fractures | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) FR (Completed) HU (Completed) NL (Completed) CZ (Completed) IT (Completed) DK (Completed) EE (Completed) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006692-20 | Sponsor Protocol Number: independant Trial (TOMIBA-TRIAL01) | Start Date*: 2007-09-06 |
Sponsor Name:St. Vincent Hospital, Medical Department II | ||
Full Title: The TOMIBA study Treatment of Osteoporotic Men With Intravenous Ibandronate An open-label, single-center, prospective Phase III study | ||
Medical condition: Osteoporosis in Men | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-000512-17 | Sponsor Protocol Number: 20040138 | Start Date*: 2004-10-01 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-controlled Study to Evaluate AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer | |||||||||||||
Medical condition: Bone loss in pateints undergoing androgen-deprivation therapy (ADT) for non-metastatic prostate cancer. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FI (Completed) HU (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003574-66 | Sponsor Protocol Number: 34964 | Start Date*: 2013-01-04 | |||||||||||
Sponsor Name:Ortopædkirurgisk Forskning - Aarhus Universitetshospita | |||||||||||||
Full Title: Osseointegrated transdermal femoral amputation prostheses - Denusomab Trial | |||||||||||||
Medical condition: leg amputee | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002693-66 | Sponsor Protocol Number: 0822-018 | Start Date*: 2007-11-13 | |||||||||||
Sponsor Name:MERCK SHARP & DOHME CORP. | |||||||||||||
Full Title: A Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of MK-0822 to Reduce the Risk of Fracture in Osteoporotic Postmenopausal Women Treated With Vitamin D an... | |||||||||||||
Medical condition: Postmenopausal Osteoporosis | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Female | ||||||||||||
Trial protocol: LT (Completed) DK (Completed) CZ (Prematurely Ended) PL (Prematurely Ended) GB (Prematurely Ended) DE (Completed) FR (Prematurely Ended) BE (Prematurely Ended) LV (Completed) EE (Completed) IT (Completed) ES (Completed) BG (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004817-16 | Sponsor Protocol Number: MACI00206 | Start Date*: 2008-01-23 | ||||||||||||||||
Sponsor Name:Genzyme Europe B.V. | ||||||||||||||||||
Full Title: A Prospective, Randomized, Open-Label, Parallel-Group, Multicenter Study to Demonstrate the Superiority of Matrix-induced Autologous Chondrocyte Implantation (MACI® implant) versus Arthroscopic Mi... | ||||||||||||||||||
Medical condition: Symptomatic Articular Cartilage Defects of the Femoral Condyle including the Trochlea. osteochondritis dissecans lesions that do not require a bone graft. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) CZ (Completed) SE (Completed) NL (Completed) PL (Completed) DE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-000931-18 | Sponsor Protocol Number: EL-THOS-001 | Start Date*: 2014-05-27 |
Sponsor Name:Ersi Voskaridou-Dimoula | ||
Full Title: EVALUATION OF EFFICACY OF DENOSUMAB IN PATIENTS WITH THALASSEMIA MAJOR AND OSTEOPOROSIS: A RANDOMIZED, PLACEBO-CONTROLLED, SINGLE-SITE, DOUBLE BLIND PHASE 2B CLINICAL TRIAL | ||
Medical condition: Adult patients with Thalassemia major and osteoporosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000926-21 | Sponsor Protocol Number: AMSC-BDT-002 | Start Date*: 2016-10-06 | |||||||||||
Sponsor Name:Fakultní nemocnice Hradec Králové | |||||||||||||
Full Title: Innovation of method cryopreservation for clinical use autologous multipotent mesenchymal stem cells (MSCs) for treatment of extensive skeletal defects in revision surgery of total hip arthroplasty+ | |||||||||||||
Medical condition: Revision total hip arthroplasty | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005991-28 | Sponsor Protocol Number: 20060326 | Start Date*: 2009-06-26 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: A Randomized, Placebo-controlled, Multi-dose Phase 2 Study to Determine the Efficacy, Safety and Tolerability of AMG 785 in the Treatment of Postmenopausal Women with Low Bone Mineral Density | |||||||||||||
Medical condition: Postmenopausal osteoporosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: AT (Completed) ES (Completed) DK (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000434-35 | Sponsor Protocol Number: 20120156 | Start Date*: 2013-12-10 | |||||||||||
Sponsor Name:Amgen, Inc | |||||||||||||
Full Title: A Multicenter, Randomized, Multiple-dose Phase 3 Study to Evaluate the Noninferiority of Romosozumab at a 90 mg/mL Concentration Compared With a 70 mg/mL Concentration in Postmenopausal Women With... | |||||||||||||
Medical condition: Postmenopausal osteoporosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: PL (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2023-000007-39 | Sponsor Protocol Number: N/A. | Start Date*: 2023-03-23 | |||||||||||
Sponsor Name:Aarhus University Hospital, Department of Endocrinology and Internal Medicine | |||||||||||||
Full Title: Bisphosphonate vs. Placebo Prior to Parathyroidectomy in Primary Hyperparathyroidisme: A Randomized, blinded Placebo-controlled Trial | |||||||||||||
Medical condition: Osteopenia i.e. bone mineral density T-score < -1 in patients with primary hyperparathyroidism | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001456-11 | Sponsor Protocol Number: 20070337 | Start Date*: 2012-04-17 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: A Multicenter, International, Randomized, Double-blind, Placebo controlled, Parallel-group Study to Assess the Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis | |||||||||||||
Medical condition: Postmenopausal Osteoporosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: HU (Completed) BE (Completed) DK (Completed) PL (Completed) DE (Completed) GB (Completed) EE (Completed) CZ (Completed) ES (Completed) LV (Completed) LT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010205-37 | Sponsor Protocol Number: 20080098 | Start Date*: 2009-10-28 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Compare the Efficacy and Safety of Denosumab versus Placebo in Males with Low Bone Mineral Density | |||||||||||||
Medical condition: Male Osteoporosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: SE (Completed) BE (Completed) FR (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.